TY - JOUR
T1 - Oral PrEP use and intention to use long-acting PrEP regimens among MSM accessing PrEP via governmental and non-governmental provision pathways, 20 European countries, October 2023 to April 2024
AU - Wang, Haoyi
AU - Lozano, Alejandro Adriaque
AU - Kolstee, Johann
AU - Zimmermann, Hanne M. L.
AU - Tosh, Jonathan
AU - Schroeder, Melanie
AU - Appiah, Ama
AU - Jonas, Kai J.
PY - 2025/8/28
Y1 - 2025/8/28
N2 - Background: Pre-exposure prophylaxis (PrEP) provision routes across Europe differ notably between governmental and non-governmental pathways. The introduction of long-acting (LA)-PrEP may further diversify provision dynamics. Aim: We investigated disparities in PrEP access and whether access pathways determine oral PrEP use patterns and LA-PrEP intention among PrEP-experienced men who have sex with men (MSM). Methods: Using data from 7,505 PrEP-experienced MSM from a cross-sectional survey (PROTECT; 20 European countries, October 2023-April 2024), we used latent class analysis (LCA) to identify MSM's latent socioeconomic positions (SEPs), and logistic regression to compare the likelihood of accessing governmental/non-governmental pathways, and compare oral PrEP adherence, discontinuation and LA-PrEP intention between governmental/non-governmental pathways. Results: Most MSM accessed PrEP via governmental pathways (n = 6,671; 88.9%), 11.1% (n = 834) used non-governmental pathways. The LCA identified three groups: employed MSM with more advantaged SEPs, younger MSM with less advantaged SEPs, and older MSM with more advantaged SEPs. Compared with the first group, younger MSM with less advantaged SEPs were significantly more likely to access PrEP via nongovernmental pathways (aOR = 1.27; 95% confidence interval (CI): 1.04-1.55). Accessing PrEP via non-governmental pathways was associated with suboptimal adherence (aOR = 1.28; 95% CI: 1.03-1.58), discontinuation (aOR = 3.55; 95% CI:2.99-4.21), but also higher LA-PrEP intention (aOR = 1.28; 95% CI: 1.06-1.56). Conclusion: Inequalities exist in PrEP access among MSM in Europe. While non-governmental pathways offer opportunities to engage MSM with less advantaged SEPs, oral PrEP use patterns via this pathway were not optimal. Tailored efforts should ensure that PrEP is accessible and affordable to enhance current use and prepare for future LA-PrEP modalities.
AB - Background: Pre-exposure prophylaxis (PrEP) provision routes across Europe differ notably between governmental and non-governmental pathways. The introduction of long-acting (LA)-PrEP may further diversify provision dynamics. Aim: We investigated disparities in PrEP access and whether access pathways determine oral PrEP use patterns and LA-PrEP intention among PrEP-experienced men who have sex with men (MSM). Methods: Using data from 7,505 PrEP-experienced MSM from a cross-sectional survey (PROTECT; 20 European countries, October 2023-April 2024), we used latent class analysis (LCA) to identify MSM's latent socioeconomic positions (SEPs), and logistic regression to compare the likelihood of accessing governmental/non-governmental pathways, and compare oral PrEP adherence, discontinuation and LA-PrEP intention between governmental/non-governmental pathways. Results: Most MSM accessed PrEP via governmental pathways (n = 6,671; 88.9%), 11.1% (n = 834) used non-governmental pathways. The LCA identified three groups: employed MSM with more advantaged SEPs, younger MSM with less advantaged SEPs, and older MSM with more advantaged SEPs. Compared with the first group, younger MSM with less advantaged SEPs were significantly more likely to access PrEP via nongovernmental pathways (aOR = 1.27; 95% confidence interval (CI): 1.04-1.55). Accessing PrEP via non-governmental pathways was associated with suboptimal adherence (aOR = 1.28; 95% CI: 1.03-1.58), discontinuation (aOR = 3.55; 95% CI:2.99-4.21), but also higher LA-PrEP intention (aOR = 1.28; 95% CI: 1.06-1.56). Conclusion: Inequalities exist in PrEP access among MSM in Europe. While non-governmental pathways offer opportunities to engage MSM with less advantaged SEPs, oral PrEP use patterns via this pathway were not optimal. Tailored efforts should ensure that PrEP is accessible and affordable to enhance current use and prepare for future LA-PrEP modalities.
KW - HIV PREEXPOSURE PROPHYLAXIS
KW - MEN
KW - ADHERENCE
KW - CARE
U2 - 10.2807/1560-7917.ES.2025.30.34.2500122
DO - 10.2807/1560-7917.ES.2025.30.34.2500122
M3 - Article
SN - 1560-7917
VL - 30
JO - Eurosurveillance
JF - Eurosurveillance
IS - 34
M1 - 2500122
ER -